Epibiotech Co., Ltd. (XKON:446440)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,120
+430 (2.74%)
At close: Nov 21, 2025

Epibiotech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022FY 2021
Period Ending
Nov '25 Dec '22 Dec '21
Debt / Equity Ratio
0.420.420.28
Asset Turnover
0.040.04-
Inventory Turnover
14.2114.21-
Quick Ratio
1.291.293.37
Current Ratio
1.371.373.80
Return on Equity (ROE)
-62.73%-62.73%-
Return on Assets (ROA)
-28.39%-28.39%-
Return on Capital (ROIC)
-29.34%-29.34%-
Return on Capital Employed (ROCE)
-76.70%-76.70%-30.10%
Buyback Yield / Dilution
--0.60%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.